Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

33.3%

1 terminated/withdrawn out of 3 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

67%

2 trials in Phase 3/4

Results Transparency

100%

2 of 2 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

Phase 4
2(66.7%)
N/A
1(33.3%)
3Total
Phase 4(2)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT04224987Phase 4Completed

Azithromycin for Child Survival in Niger: Mortality and Resistance Trial

Role: collaborator

NCT05288023Phase 4Terminated

Azithromycin for Child Survival in Niger: Programmatic Trial (AVENIR)

Role: collaborator

NCT00682708Not ApplicableCompleted

Sentinel Surveillance of Malnutrition, Niger

Role: collaborator

All 3 trials loaded